ACI’s Precision Medicine Congress will bring together senior executives and experts from top Pharma and Biopharma companies, Technology Providers, Research Institutes and leading Academia within the industry to discuss the latest challenges and developments making an impact on the industry.

The 2018 event will take place in Berlin, Germany on the 7th and 8th of November. The conference intends to examine Precision Medicine in depth, with presentations and discussions on key topics such as regulatory compliance, case studies of ongoing trials, the role of Bio-banking as well as examining what the future may hold for an industry with huge potential.

At the event there will be a key focus on collaboration between all sectors of the industry to understand the needs of each stakeholder and identifying how this can be improved in the future. This event will also allow for plenty of time for networking, Q&A’s and open discussion to ensure that all attendees get a chance to put their opinion across and make this Precision Medicine Congress as interactive as possible.

Key Topics

Confirmed Speakers

• Thomas Hach, Director, Health Care Systems, Novartis
• Svetlana Mukhina, Manager Global Regulatory Affairs, Biomarkers And Diagnostics, Merck KGaA
• Alain Bindels, Digital Innovation Lab Director, Roche
• Birgitte Sørgaard, Divisional Director: Clinical & Quantitative Pharmacology, Lundbeck
• Karin Hygge Blakeman, Head of Medical Affairs: Nordics, Grunenthal
• Gautam Goel, Director, Precison Medicine. ImmusanT
• Laurent Dolle, Managing Director, Biotheque Wallonie Bruxelles 
• Tim Fugmann, Head of Precision Medicine, Philochem
• Sudhakaran Prabakaran, Lecturer, Department Of Genomics, University Of Cambridge
• Tony Freemont, Procter Professor of Pathology, University Of Manchester
• Harun Badakhshi, Director of the Department of Clinical Radiation Oncology, Humboldt University

Who will attend

MORE ABOUT THIS EVENT | Register